Alogliptin plus metformin initial combination therapy was well tolerated yet more efficacious in controlling glycemia in drug-naïve T2DM patients than either as monotherapy (Diabetes, Obesity and Metabolism)
Diabetes News Service
Glycosmedia is also available as an App:
For iPhone and iPad | For Android devices
Sponsorship and Advertising
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
